Pjd. Foxall et al., URINARY PROTON MAGNETIC-RESONANCE STUDIES OF EARLY IFOSFAMIDE-INDUCEDNEPHROTOXICITY AND ENCEPHALOPATHY, Clinical cancer research, 3(9), 1997, pp. 1507-1518
Ifosfamide Is an oxazophosphorine widely used in the treatment of canc
er in children and adults, Nephrotoxicity and neurotoxicity are major
side effects, The aim of this study was to use high-resolution proton
nuclear magnetic resonance (H-1 NMR) spectroscopy of urine to identify
novel biochemical markers of ifosfamide-induced toxicity, Urine sampl
es were collected from 10 nonencephalopathic patients (who had not pre
viously received nephrotoxic chemotherapy) immediately prior to the fi
rst ifosfamide dose and at timed intervals for up to four treatment cy
cles, The findings were compared with those for urine samples collecte
d from five patients during acute encephalopathic episodes. H-1 NMR ur
inalysis identified a series of characteristic time related changes in
the excretion profiles of low molecular weight endogenous metabolites
during ifosfamide therapy, These changes included a decreased excreti
on of hippurate and an increased excretion of glycine, histidine, gluc
ose, lactate, and trimethylamine-N-oxide. Two nonencephalopathic patie
nts had marked but transient glutaric or adipic aciduria during the se
cond cycle of ifosfamide treatment, Urinary retinol-binding protein ro
se acutely after each treatment cycle but usually returned to baseline
levels. Maximum renal toxicity was observed by the fourth treatment c
ycle, The ratio of the urinary excretion of the uroprotectant mesna (a
ctive form) to dimesna (inactive form) correlated with the degree of r
enal toxicity, For the encephalopathic patients, the ifosfamide-induce
d changes in the urinary low molecular weight metabolite profile were
similar to those for the nonencephalopathic group, In contrast to prev
ious re ports, none of the encephalopathic group developed glutaric ac
iduria, and i.v. methylene blue did not reverse neurotoxicity in the t
wo patients who received it, The results suggest that ifosfamide nephr
otoxicity involves both cortical and medullary regions of the nephron
and that the urinary mesna:dimesna ratio may be important in assessing
the degree of cytoprotection. This study demonstrates that H-1 NMR ca
n provide novel biochemical information on ifosfamide-induced toxicity
and will be of value in the optimization of ifosfamide therapy.